Now, it’s worth noting Stock Advisor’s total average return is 986 % — a market-crushing outperformance compared to 199% for ...

Arrowhead Pharmaceuticals stock could build on its rally in the third quarter, Morgan Stanley says.

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

Legend Biotech ( LEGN +18.42%) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...

Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the best low priced biotech stocks to invest in. On April 13, Vir ...

We'll know more about the company's medium-term prospects by the end of the year.

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same ...

Biogen is likely to get a big boost from its increased focus on developing drugs for kidney transplant patients and ...

Legend Biotech Corporation (NASDAQ:LEGN) is one of the 10 Overlooked Growth Stocks to Buy Now. Legend Biotech Corporation ...

Nektar Therapeutics releases positive results from its trial for the treatment of alopecia areata.

Legend Biotech reported that more than 10,000 patients have now been treated with its CARVYKTI multiple myeloma therapy. The company announced an expansion of its Raritan facility, which it says is ...